Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes
in patients with relapsed/refractory multiple myeloma
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes
in patients with relapsed/refractory multiple myeloma